Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcjo.2015.12.005 | DOI Listing |
AAPS PharmSciTech
January 2025
OSIS, Silver Spring, Maryland, U.S.A.
Travel restrictions during the novel coronavirus, SARS-CoV-2 (COVID-19) public health emergency affected the U.S. Food and Drug Administration's (FDA) ability to conduct on-site bioavailability/bioequivalence (BA/BE) and Good Laboratory Practice (GLP) nonclinical inspections.
View Article and Find Full Text PDFCompr Psychiatry
December 2024
Laboratory of Behavioral Medicine, Neuroscience Institute, Lithuanian University of Health Sciences, Kaunas-Palanga, Lithuania.
Background: Cardiovascular diseases such as coronary artery disease (CAD) have a high prevalence of psychiatric comorbidities, that may impact clinically relevant outcomes (e.g., cognitive impairment and executive dysfunction).
View Article and Find Full Text PDFFront Microbiol
December 2024
Department of Food Science and Technology, University of Georgia, Athens, GA, United States.
Introduction: Recycling drenchers used to apply postharvest fungicides in pome fruit may spread microorganisms, i.e., plant and foodborne pathogens, that increase fruit loss and impact food safety.
View Article and Find Full Text PDFNeurol Educ
December 2024
From the Department of Neurology (W.A.D., A.M.S.), University of Virginia, Charlottesville; Department of Neurology (R.U.), Icahn School of Medicine at Mount Sinai, New York, NY; Department of Neurology (J.B.R.), Thomas Jefferson University, Philadelphia, PA; Department of Neurology (J.C.), University of Michigan Medical School, Ann Arbor; Department of Neurology (A.W.), University of Arizona College of Medicine - Phoenix; and Department of Public Health Sciences (J.T.P., A.M.S.), University of Virginia, Charlottesville.
Background And Objectives: The residency application process relies on interviews, which allow programs and applicants to assess one another. Historically, interviews were conducted in person at each program. With the advent of the coronavirus disease 2019 pandemic, residency interviews shifted to a virtual format.
View Article and Find Full Text PDFPart 2 explores the transformative potential of artificial intelligence (AI) in addressing the complexities of headache disorders through innovative approaches, including digital twin models, wearable healthcare technologies and biosensors, and AI-driven drug discovery. Digital twins, as dynamic digital representations of patients, offer opportunities for personalized headache management by integrating diverse datasets such as neuroimaging, multiomics, and wearable sensor data to advance headache research, optimize treatment, and enable virtual trials. In addition, AI-driven wearable devices equipped with next-generation biosensors combined with multi-agent chatbots could enable real-time physiological and biochemical monitoring, diagnosing, facilitating early headache attack forecasting and prevention, disease tracking, and personalized interventions.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!